LHS.CN - Liberty Health Sciences Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD

Liberty Health Sciences Inc.

35 McCaul Street
2nd Floor Suite 201
Toronto, ON M5T 1V7
Canada
647-709-0244
http://www.libertyhealthsciences.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees75

Key Executives

NameTitlePayExercisedYear Born
Mr. Victor E. ManceboInterim CEO & PresN/AN/AN/A
Mr. Brady CobbPresN/AN/AN/A
Ms. Sheri CholodofskyChief Financial OfficerN/AN/AN/A
Ms. Stephanie KubackiVP of MarketingN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Liberty Health Sciences Inc. engages in the production and distribution of medical cannabis primarily in the State of Florida. As of June 17, 2019, the company operated 15 dispensaries. It has a strategic partnership with Veterans Cannabis Project to support various research projects focused on the treatment of service related trauma with cannabis derived products; and partnership with AdaViv Inc. to enhance production of cannabis. The company is headquartered in Toronto, Canada.

Corporate Governance

Liberty Health Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.